|
|
| | Cinacalcet IMpurity 5 Basic information |
| Product Name: | Cinacalcet IMpurity 5 | | Synonyms: | (E)-N-(1-(7,8-dihydrophthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)acrylamide;3'-Destrifluoromethyl 2'-Trifluoromethyl Cinacalcet;Cinacalcet Hydrochloride iMpuritF;Cinacalcet Impurity 87;1-Naphthalenemethanamine, α-methyl-N-[3-[2-(trifluoromethyl)phenyl]propyl]-, (αR)-;Cinacalcet ortho isomer-(3-(2-(trifluoromethyl)phenyl)-N-((R)-1-(naphthalen-5-yl)ethyl)propan-1-amine) | | CAS: | 1431699-53-4 | | MF: | C22H22F3N | | MW: | 357.42 | | EINECS: | | | Product Categories: | | | Mol File: | 1431699-53-4.mol |  |
| | Cinacalcet IMpurity 5 Chemical Properties |
| Boiling point | 439.7±45.0 °C(Predicted) | | density | 1.154±0.06 g/cm3(Predicted) | | solubility | Dichloromethane, Ethyl Acetate, Methanol | | form | Oil | | pka | 9.15±0.29(Predicted) | | color | Pale |
| | Cinacalcet IMpurity 5 Usage And Synthesis |
| Uses | 3''-Destrifluoromethyl 2''-Trifluoromethyl Cinacalcet is an intermediate in synthesizing 3''-Destrifluoromethyl 2''-Trifluoromethyl Cinacalcet Hydrochloride (D297820), a related compound of Cinacalcet Hydrochloride (C441800), which is the (R) enantiomer of Cinacalcet. Used in clinical trial in secondary hyperparathyroidism. |
| | Cinacalcet IMpurity 5 Preparation Products And Raw materials |
|